Anti-HAV ELISA

Anti-HAV ELISA
520€ (96 det.)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Anti-HAV ELISA
Category
ELISA Kits
Provider
Mediagnost
Reference
E10
Tested Applications
Elisa

Description

Mediagnost anti-HAV ELISA, (Ref: E10) is an enzyme immunoassay for the detection of antibodies against Hepatitis A virus in Human Serum for research use.

Descripción

Mediagnost anti-HAV ELISA, (Ref: E10) es un inmunoensayo enzimático para la detección de anticuerpos contra el virus de la hepatitis A en suero humano para uso en investigació

Documentos del producto

Instrucciones
Descargar
Data sheet

Especificaciones del producto

Category
ELISA Kits
Reactivity
Human
Assay Data
Reference Material: WHO 97/646
Incubation Period: 3.5h
Calibrator: human IgG
Controls:  2 controls ready for use
Assay Type
pseudo-competitive
Test Range
0–50  IU/L
Recommended Dilution
0.048611111
Origin
Antibody: Mouse / Human
Size 1
96 det.
Tested Applications
Elisa
Sample Type
Serum
EDTA / Heparin Plasma
Availability
3-5 days.
Storage
Shelf life: between 1 and 2 years. Inquire about availability.
Store the kit at 2-8°C after receipt until its expiry date
Alias
HAVIgG
Background
Elisa Kits for: HAV IgG
Status
RUO
Note
Intra/Interassay Variance [%]<30

Background

After infection with the Hepatitis A-Virus, neutralising antibodies appear at the same time of AntiHAV of IgG-Class formation. The Anti-HAV titers 3 to 6 months after naturally occurring infections are very high, within the range of 100 to more than 300 International Units per ml (IU/ml). Even after more than 10 years the titers usually remain at more than 1 to 10 IU/ml. A value of 10 - 30 (mIU/ml) milli International Units can be considered the minimal protective level. Since the incidence of HAV infection in children has diminished in Northern Europe in recent years, children and juveniles are predominantly Anti-HAV negative. In an adult population could be observed, that the percentage of anti-HAV positive individuals raises with increasing age: only 3.9 % of the young people (18-24 years) show antibody against HAV, where as in older population (≥50 years) HAV-Antibody was found in 40.3 % of the population. In countries around the Mediterranean area, Africa or Asia, the incidence is very high.

Productos relacionados

E11

Anti-HAV IgM ELISA

The Mediagnost anti-HAV IgM ELISA is a "class-capture" enzyme immuoassay. Serum or plasma samples are diluted 1:2000 and…

Ver producto
E12

Hepatitis A-Virus Antigen (HAV) ELISA

Enzyme immunoassay for the qualitative detection of hepatitis A virus antigen in human stool specimens.Early detection o…

Ver producto